82717-96-2,
(S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoic acid,
N-[(S)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine,
UNII-10SZ4IJ77B,
MFCD00209976,
N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine,
N-[1-(S)-(Ethoxycarbonyl)-3-Phenylpropyl]-L-Alanine,
10SZ4IJ77B,
N-[(S)-(+)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanine,
N-[(S)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanine,
(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoic acid,
(+)-N-[1-(S)-Ethoxycarbonxyl-3-phenylpropyl]-L-alanine,
(2S)-2-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}propanoic acid,
(S,S)-N-(Ethoxy Carbonyl-3-Phenylpropyl)Alanine,
N-[1(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanine,
Enalapril EP Impurity B,
N-(1-(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanine,
(S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoic acid,
(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]propanoic Acid,
(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoic acid,
80828-26-8,
AK-76568,
Enalapril IMpurity B,
AC1NWBKI,
PubChem20772,
N-[1-(s)-ethoxycarbonyl-3-phenylpropyl]-l-alanine,
(S,S)-N-(1-ETHOXYCARBONYL-3-PHENYLPROPYL)ALANINE,
SCHEMBL497515,
CTK5E9968,
KS-00000AMS,
CEIWXEQZZZHLDM-AAEUAGOBSA-N,
ZINC2557974,
ANW-37604,
CE-036,
SBB063223,
AKOS015843325,
AKOS015888218,
AB04805,
CS-W010059,
Benzenebutanoic acid, alpha-((1-carboxyethyl)amino)-, monoethyl ester, (S-(theta,theta))-,
AJ-40083,
BR-76568,
DS-16718,
H563,
SC-17772,
AB0013122,
AX8022763,
TC-010254,
TC-066484,
E0530,
FT-0629610,
ST24020796,
M-5282,
N-[1(S)-carboethoxy-3-phenylpropyl]-(S)-alanine,
J-502555,
(S,S)-N-(1-Ethoxycarbonyl-3-phenylpropyl)-L-alanine,
N-[(lS)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanine,
N-[1-(S)-ethoxy carbonyl-3-phenyl propyl]-L-alanine,
N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanine,
N-[(S)-(+)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine,
N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanine,
(S)-N-(1-ETHOXYCARBONYL-3-PHENYLPROPYL)-(S)-ALANIN,
N-[(S)-(+)-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine, 97%,
(S)-2-[(S)-1-(ethoxycarbonyl)-3-phenylpropylamino]propanoic acid,
N-[(S)-(+)-1-(Ethoxycarbonyl)-3-phenylpropyl]-L-alanine, 98%,
(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino]propionic acid,
a-[[(1S)-1-Carboxyethyl]amino]-benzenebutanoic acid 1-ethyl ester hydrochloride (1:1),
Benzenebutanoic acid, a-[[(1S)-1-carboxyethyl]amino]-,1-ethyl ester, (aS)-,
Moexipril Related Compound F, United States Pharmacopeia (USP) Reference Standard,
C15-H21-N-O4,
CID5702571,
CS-O-08084,
N-[ - -1- -3-phenylpropyl]-L-alanine,
EC 406-310-6,
(S-)-N-(1-Ethoxycarb.-3-phenylpropyl)-(S)-alanin,
N-[(S)-1-Carboxyethyl]-L-homophenylalanine Ethyl Ester,
2-[(1-ethoxycarbonyl-3-phenyl-propyl)amino]propanoic Acid,
(2S)-2-(((1S)-1-(Ethoxycarbonyl)-3-phenylpropyl)amino)propanoic acid,
(2S)-2-(((2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoic acid,
(S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoicacid,
Benzenebutanoic acid, ?-[(1-carboxyethyl)amino]-, monoethyl ester, [S-(R,R)]-,
N-[(S)-( )-1-Ethoxycarbonyl-3-phenylpropyl]-L-alanine, 97% - 100G 100g,